The DLBCL90 gene‐expression assay identifies double‐hit lymphomas with high sensitivity in patients from two phase II clinical trials with high‐risk diffuse large B‐cell lymphoma

Bibliographic Details
Main Authors:	Kathrine T. Isaksen, Klaus Beiske, Erlend B. Smeland, Judit Jørgensen, Marianne Brodtkorb, June Helen Myklebust, Mats Jerkeman, Leo Meriranta, Marja‐Liisa Karjalainen‐Lindsberg, Sirpa Leppä, David W. Scott, Harald Holte, Yngvild Nuvin Blaker
Format:	Article
Language:	English
Published:	Wiley 2021-02-01
Series:	eJHaem
Online Access:	https://doi.org/10.1002/jha2.109

Internet

https://doi.org/10.1002/jha2.109